Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel therapeutic strategies for Alzheimer’s disease targeting brain cholesterol homeostasis
Nikita Patil Samant, Girdhari Lal Gupta
European Journal of Neuroscience (2020) Vol. 53, Iss. 2, pp. 673-686
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Oxidative Stress and Beta Amyloid in Alzheimer’s Disease. Which Comes First: The Chicken or the Egg?
Elena Tamagno, Michela Guglielmotto, Valeria Vasciaveo, et al.
Antioxidants (2021) Vol. 10, Iss. 9, pp. 1479-1479
Open Access | Times Cited: 149
Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification
Jeffrey L. Cummings, Amanda M. Leisgang Osse, Jefferson W. Kinney
Drugs (2023) Vol. 83, Iss. 15, pp. 1387-1408
Open Access | Times Cited: 65
Statin use and dementia risk: A systematic review and updated meta‐analysis
Fernando Luiz Westphal Filho, Paulo Roberto Moss Lopes, Artur Menegaz de Almeida, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 3
Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease
Ángeles Vinuesa, Carlos Pomilio, Amal Gregosa, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 65
The role of statins in amyotrophic lateral sclerosis: protective or not?
Hayder M. Al‐kuraishy, Majid S. Jabir, Ghassan M. Sulaiman, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 10
Statins and cognition: Modifying factors and possible underlying mechanisms
Tahereh Jamshidnejad-Tosaramandani, Soheila Kashanian, Mohamed H. Al-Sabri, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 30
Amyloid β, Lipid Metabolism, Basal Cholinergic System, and Therapeutics in Alzheimer’s Disease
Victoria Campos‐Peña, Pavel Pichardo-Rojas, Talía Sánchez-Barbosa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12092-12092
Open Access | Times Cited: 26
Simvastatin rescues memory and granule cell maturation through the Wnt/β-catenin signaling pathway in a mouse model of Alzheimer’s disease
Xin‐Kang Tong, Jessika Royea, Édith Hamel
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 24
Current druggable targets for therapeutic control of Alzheimer's disease
Girdhari Lal Gupta, Nikita Patil Samant
Contemporary Clinical Trials (2021) Vol. 109, pp. 106549-106549
Closed Access | Times Cited: 32
Amyloid beta increases ABCA1 and HMGCR protein expression, and cholesterol synthesis and accumulation in mice neurons and astrocytes
Shirin Azizidoost, Hossein Babaahmadi‐Rezaei, Zahra Nazeri, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2021) Vol. 1867, Iss. 1, pp. 159069-159069
Closed Access | Times Cited: 28
Current understandings and perspectives of petroleum hydrocarbons in Alzheimer’s disease and Parkinson’s disease: a global concern
Rajalakshmi Rajendran, Roshni Pushpa Ragavan, Abdullah G. Al‐Sehemi, et al.
Environmental Science and Pollution Research (2022) Vol. 29, Iss. 8, pp. 10928-10949
Closed Access | Times Cited: 17
The association between tooth loss and cognitive decline in the aged population: The mediating role of HDL-cholesterol
Hui Min Chen, Kar Yan Li, Tian Le Li, et al.
Journal of Dentistry (2023) Vol. 135, pp. 104570-104570
Closed Access | Times Cited: 10
Neurodegenerative Diseases and Cholesterol: Seeing the Field Through the Players
Frank W. Pfrieger
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 21
Molecular and Computational Analysis Identify Statins as Selective Inhibitors of Human Butyrylcholinesterase
Melvin Selim Atay, Suat Sarı, Ebru Bodur
The Protein Journal (2023) Vol. 42, Iss. 2, pp. 104-111
Closed Access | Times Cited: 9
The role of the ATP-Binding Cassette A1 (ABCA1) in neurological disorders: a mechanistic review
Tahere Paseban, Mohaddeseh Sadat Alavi, Leila Etemad, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 7, pp. 531-552
Closed Access | Times Cited: 9
Genetic mutations of APOEε4 carriers in cardiovascular patients lead to the development of insulin resistance and risk of Alzheimer's disease
Komal Jabeen, Kanwal Rehman, Muhammad Sajid Hamid Akash
Journal of Biochemical and Molecular Toxicology (2021) Vol. 36, Iss. 2
Closed Access | Times Cited: 20
Oligodendroglia-to-pericyte conversion after lipopolysaccharide exposure is gender-dependent
Qingting Yu, Linyuan Zhang, Ting Xu, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0308132-e0308132
Open Access | Times Cited: 2
Fundamental neurochemistry review: Old brain stories ‐ Influence of age and sex on the neurodegeneration‐associated lipid changes
Lorena Cuenca‐Bermejo, Alessandro Prinetti, Karolina Kublickiene, et al.
Journal of Neurochemistry (2023) Vol. 166, Iss. 3, pp. 427-452
Open Access | Times Cited: 6
Contextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer’s Disease
Roshni C. Lalwani, Claude‐Henry Volmar, Claes Wahlestedt, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3232-3232
Open Access | Times Cited: 6
Mesenchymal stem cell‐derived rapid drug screening system for Alzheimer's disease for the identification of novel drugs
Naisarg Gamit, Manasi Patil, Soumya B Sundrappa, et al.
Drug Development Research (2023) Vol. 84, Iss. 7, pp. 1496-1512
Open Access | Times Cited: 4
Curcumin ameliorates lipid metabolic disorder and cognitive dysfunction via the ABCA1 transmembrane transport system in APP/PS1 double transgenic mice
Mingyuan Tian, Fanlin Zhou, Zhipeng Teng, et al.
Journal of Integrative Neuroscience (2021) Vol. 20, Iss. 4, pp. 895-903
Open Access | Times Cited: 10
A Revisit to Etiopathogenesis and Therapeutic Strategies in Alzheimer’s Disease
Manish Kumar, Nitin Bansal
Current Drug Targets (2021) Vol. 23, Iss. 5, pp. 486-512
Closed Access | Times Cited: 8
Specific Mutations in the Cholesterol-Binding Site of APP Alter Its Processing and Favor the Production of Shorter, Less Toxic Aβ Peptides
Linda Hanbouch, Béatrice Schaack, Amal Kasri, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 11, pp. 7056-7073
Open Access | Times Cited: 5
Cholesterol synthesis inhibition or depletion in axon regeneration
BorLuen Tang
Neural Regeneration Research (2021) Vol. 17, Iss. 2, pp. 271-271
Open Access | Times Cited: 7
The influences of cholesterol and AC0107 inhibitor molecules on the amyloid-beta fibrils aggregation in cell membranes: molecular modeling approach
N. Salehi, A. Lohrasebi, M. Rezaeisaadaat, et al.
The European Physical Journal Plus (2022) Vol. 137, Iss. 4
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top